Table 2.
Defect | Na | % T1 NVP | Crude OR (CI) | Adjusted ORb (CI) |
---|---|---|---|---|
CL/P | 1,546 | 64.5 | 0.83 (0.74–0.93) | 0.87 (0.76–0.98) |
CP | 821 | 67.0 | 0.93 (0.79–1.08) | 0.93 (0.80–1.09) |
NTD | 1,038 | 69.1 | 1.02 (0.89–1.18) | 1.00 (0.86–1.16) |
Controls | 5,859 | 68.6 | Reference | Reference |
Hypospadiasc | 1,144 | 60.5 | 0.77 (0.67–0.88) | 0.84 (0.72–0.98) |
Male controls | 2,946 | 66.6 | Reference | Reference |
NVP=nausea and vomiting of pregnancy, T1=trimester 1, CL/P=cleft lip with or without cleft palate, CP=cleft palate only, NTD=neural tube defect
Number of subjects with completed interviews and data on NVP and medication use.
Adjusted for maternal age, race/ethnicity and education, parity, plurality, previous miscarriage, any smoking in the month before conception through the first trimester, body mass index, any use of folic acid in the month before conception through the first trimester, expected year of delivery and site. CL/P, CP, and NTDs are also adjusted for infant sex.
Hypospadias analysis uses only male controls.